Preservation of form and function during management of cancer of the larynx and hypopharynx

World Journal of Surgery

Volumn 27, Issue 7, 2003, Pages 811-816

  Lefebvre, Jean Louis ^a   Lartigau, Eric ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DOSIMETRY; HUMAN; HYPOPHARYNX CANCER; LARYNGECTOMY; LARYNX CANCER; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; NEOPLASM STAGING; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RECOVERY OF FUNCTION; RISK ASSESSMENT; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0041428080     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7106-5     Document Type: Review

References (31)

1. Karp DD, Vaughan CW, Carter R, et al. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer: a long-term follow-up report. Am. J. Clin. Oncol. 1991;14:273
2. Pfister DG, Strong E, Harrison L, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J. Clin. Oncol. 1991;9:850
3. Nikolaou A, Fountzilas G, Kosmidis P, et al. Larynx preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy before local treatment. J. Laryngol. Otol. 1991;105:930
4. Price LA, Hill BT. Larynx preservation after initial chemotherapy plus radiotherapy as opposed to surgical intervention with or without radiotherapy in previously untreated advanced head and neck cancer: final analysis. Proc. Am. Soc. Clin. Oncol. 1992;11:785
5. Giglio R, Mickiewicz E, Roth R, et al. Organ preservation (LP) in resectable stage III and IV epidermoid carcinoma of the larynx (LC) with sequential chemotherapy (CT) + radiotherapy (RT). Proc. Am. Soc. Clin. Oncol. 1993;13:911
6. Demard F, Chauvel P, Schneider M, et al. Induction chemotherapy for larynx preservation in laryngeal and hypopharyngeal cancers. In Johnson JT, Didolkar MS, editors, Head and Neck Cancer, vol. 3, Amsterdam, Elsevier, 1993;3-10
7. Shirinian MH, Weber RS, Lippman SM, et al. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Head Neck 1994;16:39
8. Kraus DH, Pfister DG, Harrison LB, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngol. Head Neck Surg. 1994;111:31
9. De Andres L, Brunet J, Lopez-Pousa A, et al. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol. Laryngoscope 1995;105:822
10. Zelepski MJ, Kraus DH, Pfister DG, et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Otolaryngol. J. Club 1997;4:23
11. Wolf GT, Hong WK, Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy as part of a new treatment strategy to preserve the larynx in advanced laryngeal cancer. In Johnson JT, Didolkar MS, editors, Head and Neck Cancer, vol. 3, Amsterdam, Elsevier, 1993;27-35
12. Richard JM, Sancho-Garnier H, Pessey JJ, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 1998;34:224
13. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III study. J. Natl. Cancer Inst. 1996;13:890
14. Lefebvre JL, Wolf G, Luboinski B, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC). 2. Larynx preservation using neoadjuvant chemotherapy (CT) in laryngeal and hypopharyngeal carcinoma. Proc. Am. Soc. Clin. Oncol. 1998;17:1473
15. Bourhis J, Pignon JP, Designe L, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC). 1. Loco-regional treatment vs same treatment + chemotherapy (CT). Proc. Am. Soc. Clin. Oncol. 1998;17:1486
16. Beauvillain C, Mahé M, Bourdin S, et al. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope 1997;107:648
17. Wilie JP, Sen M, Swindell R, et al. Definitive radiotherapy for 114 cases of T3N0 glottic carcinoma: influence of dose-volume parameters on outcome. Radiother. Oncol. 1999;53:15
18. Overgaard J, Hjelm-Hansen M, Vendelbo Johansen L, et al. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 1988;27:147
19. Barton MB, Keane T. Do reasons for and position of treatment interruption influence local control in laryngeal cancer? Int. J. Radiat. Oncol. Biol. Phys. 1994;30:1034
20. Parsons JT, Mendenhall WM, Mancuso AA, et al. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx. Head Neck 1989;11:23
21. Mendenhall WM, Parsons JT, Stringer SP, et al. Stage T3 squamous cell carcinoma of the glottic larynx: a comparison of laryngectomy and irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1992;23:725
22. Saunders MI, Dische S, Fowler JF, et al. Radiotherapy employing three fractions on each of twelve consecutive days. Acta Oncol. 1988;27:163
23. Dische S, Saunders MI. Continuous, hyperfractionated, accelerated fractionation (CHART): an interim report upon late morbidity. Radiother. Oncol. 1989;16:67
24. Lartigau E, Saunders MI, Dische S, et al. Comparison of the late radiation changes after three schedules of radiotherapy. Radiother. Oncol. 1991;20:139
25. Dische S, Saunders MI, Barrett A, et al. Randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 1997;44:123
26. Overgaard J, Sand Hansen H, Sapru W, et al. Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck: a randomized multicenter study of 5 versus 6 fractions per week; preliminary report from the Dahanca 6 and 7 trial. Radiother. Oncol. 1996;40:110
27. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: preliminary results of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 1999;45:1
28. Munro AJ. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br. J. Cancer 1995;71:83
29. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N. Engl. J. Med. 1992;327:1115
30. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 1998;338:1798.
31. Forastiere, AA, Berkey, B, Maor, M et al. (2001) "Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, intergroup trial R91-11" In: Proceedings of the 37th Annual Meeting of the American Society of Clinical Oncology, San Francisco, May 12-15, 2001 (abstract 4)